. Cytotoxicity of ARDP0006. BHK-21 cells were grown in the presence of increasing concentrations of ARDP0006 or its DMSO solvent for either 24 or 48 hours before assessing cell viability using the WST assay kit. Vertical dashed line at 25 µM indicates the concentration used for viral growth curves in Fig. 1 . A) Serial passage of dengue virus in BHK-21 with increasing concentration of ARDP0006 yielded two independent adapted pools of virus from which NS4A-A21V was identified as specific to selected pools versus DMSO-treated pools. B) Comparison of NS4A-A21V virus growth with WT 16681 dengue virus shows that the adapted variant grows to higher titer in both the absence and presence of ARDP0006. NS4A-A21V dengue virus cDNA was constructed by site-directed mutagenesis and used to generate viral stocks. C) NS4A-A21V virus rapidly expands relative to wild type virus in a direct competition. BHK-21 cells were coinfected with wild-type virus with a silent mutation adding an AflII restriction site and NS4A-A21V viruses at a ratio of approximately 4:1 and passaged four times. Total viral RNA in supernatants from each passage was collected and relative amounts of each allele was determined by reverse transcription followed by AflII digestion, agarose gel electrophoresis, and densitometric measurement. The presence of ARDP0006 had no effect on the relative amount of NS4A-A21V variant at any time point. The insertion of an AflII site did not alter growth of virus as discussed previously in the literature (2). D) Multiple sequence alignment of 3,871 dengue protein sequences in the region of NS4A-A21V show that Ala and Thr are the major naturally occurring variants at this site. Radioactively labeled NS2B/3 pro was produced in rabbit reticulocyte lysate extracts as described in Figure 3 in the presence of increasing concentrations of the protease inhibitor or its DMSO solvent. As was the case with ARDP006, the IC 50 for viral inhibition was much lower than for proteinase inhibition. Protease cleavage assay to determine cleavage capability of NS3-R376A mutant was performed with NS2B/3/4A constructs containing the relevant mutations as described in Fig. 4 , except products were analyzed at 30 (time of chase addition) and 60 minutes posttranslation. D) Effect of NS3-R376A genomic viral RNA on replicon luciferase production was performed as described for Fig. 5. (B, D; ns = not significant; *P < 0.05, **P < 0.01, ***P < 0.001). 1.4 x 10 6 NS3-S135A >1 x 10 9 NS3-G459L >1 x 10 9 NS4A-S1L >1 x 10 9 NS3-K199A >1 x 10 9 NS3-R376A >1 x 10 9 NS3-K396A >1 x 10 9 NS3-R463A >1 x 10 9 
